Pituitary gland volume (PGV) increases during childhood and adolescence in a sex-specific manner, and previous research suggests that puberty may be associated with PGV development. However, existing research to date has focused on sex hormones associated with gonadarche. Given the role of the pituitary gland in hypothalamicpituitary-adrenal (HPA) axis function, the present study investigated associations between PGV development and HPA hormones that play a role in the earlier pubertal phase of adrenarche.
Introduction
The pituitary gland is an endocrine gland that synthesizes and secretes a range of hormones important for a number of physiological processes that change across development (including stress, growth and reproduction). It also plays an important role in developmental psychopathology, with alterations in pituitary gland volume (PGV) suggested to confer vulnerability to a number of mental health disorders in adolescence, including depression and psychosis (MacMaster et al., 2006; Nordholm et al., 2013; Whittle et al., 2012) . As compared to other brain regions, less work has been done to map PGV development during childhood and adolescence.
Existing studies typically report 1) increases in PGV with age, 2) a growth spurt in size during puberty, and 3) sex differences, whereby females have larger sized PGV, or exhibit accelerated growth during puberty relative to males (MacMaster et al., 2007; Marziali et al., 2004; Takano et al., 1999) . These findings suggest that pubertal maturation may be as (or potentially more) important in predicting PGV development as chronological age. Indeed, the pituitary gland is an integral part of the hypothalamic-pituitary-adrenal (HPA) and hypothalamicpituitary-gonadal (HPG) axes, which become reactivated during puberty and underlie the development of reproductive maturity (Styne and Grumbach, 2011) .
Some work has been done to directly investigate links between measures of pubertal maturation (i.e., physical maturation and/or gonadal hormone levels) and PGV development. For example, Peper et al. (2010) found PGV to correlate positively with estradiol and follicle stimulating hormone (FSH) levels in females aged 10-15 years, although only the latter association remained after accounting for age. No associations were found for testosterone or luteinizing hormone (LH) levels in females, and there were no associations in males. Wong et al. (2014) found a significant positive association (after accounting for age) between self-report pubertal stage and PGV in adolescents aged 12-18 years, in addition to sex-specific associations, such that testosterone was positively associated with PGV in male adolescents, and estradiol was positively associated with PGV in pre-menarcheal females.
As such, existing work supports the notion that pubertal maturation is important to consider in understanding PGV development during childhood and adolescence. There is, however, a key gap in the current literature. Existing work has focused on the latter phase of pubertygonadarche, which is characterized by reactivation of the HPG axis, and involves secretion of gonadotropin releasing hormone (GnRH) from the hypothalamus at approximately 10-11 years of age. Gonadarche drives most of the external physical changes typically associated with puberty. GnRH regulates the production of LH and FSH from the pituitary gland (Marshall, 1995) , and in turn estradiol and testosterone secretion from the gonads (Grumbach and Styne, 2003) . No work, to date, has investigated the contribution of pubertal maturation to PGV development during adrenarche (the biochemically earlier phase of pubertal maturation), despite the involvement of the PGV in the HPA axis. Adrenarche typically begins around seven years of age, when levels of the androgens dehydroepiandrosterone (DHEA) and its sulfate, DHEA-S, regulated by the HPA axis and secreted from the adrenal glands, begin to increase, before the HPG axis is re-activated (Styne and Grumbach, 2011) . Given the role of the pituitary gland in adrenarche, its growth is thus likely to be influenced by HPA upregulation and the action of adrenal hormones during this period.
Only one study, to our knowledge, has investigated associations between adrenal hormones and PGV. In a cross-sectional analysis of children (comprising the baseline data used in the present manuscript), we found positive associations between PGV and both DHEA and DHEA-S (Murray et al., 2016) . However, it is unknown how these hormones may contribute to the development of PGV over time.
The aim of this study was to investigate age and puberty-related trajectories of PGV across childhood and early adolescence, with a focus on adrenarcheal hormones. Hormones were a primary focus given that they have organizational effects on the brain (Mellon, 2007) , and because physical signs may lag behind initial increases in hormone levels. Previous studies of age-related PGV growth have examined trajectories relatively crudely by grouping individuals into age brackets (e.g., age 5-9 years compared to age 10-14 years). As such, we first examined age-related change in PGV using a continuous measure of age. Second, we investigated the contribution of pubertal maturation, via physical maturation and adrenarcheal hormones regulated by the HPA-axis (i.e., DHEA, DHEA-S, and testosterone) to PGV development. Although testosterone is produced as a result of HPG axis maturation during gonadarche, it is metabolized in children post adrenarche via the conversion of DHEA. Testosterone metabolized via HPA pathways is the primary source of systemic testosterone in females (Prough et al., 2016) . Although gonadal hormones were not of primary interest, estradiol was available and examined in a subset of female participants. In the previous studies of gonadal hormones and PGV development, only linear associations were examined. Given suggested non-linear age-related changes in PGV (MacMaster et al., 2007) and hormones (Søeborg et al., 2014) , non-linear associations were examined here. We hypothesized nonlinear age-related increases in PGV, with females showing steeper growth than males. We hypothesized that pubertal physical maturation and adrenarcheal hormonal measures would significantly predict nonlinear PGV development, however due to a lack of prior research testing for nonlinear associations and sex differences (prior research has investigated males and females separately, but not tested for sex differences), we made no specific hypotheses about exact patterns and sex differences.
Material and methods

Participants and procedure
Participants were recruited from the community in Melbourne, Australia, into one of two longitudinal studies: the Families and Childhood Transitions Study (FACTS), and the imaging brain development in the Childhood to Adolescence Transition Study (iCATS). Although participants were from the general community, and methods across studies were similar, the recruitment procedure of the two studies differed. FACTS participants were recruited from lower socioeconomic areas in Melbourne, Australia, as described in detail elsewhere (Simmons et al., 2017) , whereas iCATS participants were recruited based on levels of DHEA and testosterone, such that those with the lowest or highest tertiles of these hormones, as measured approximately six months earlier in a larger parent project (CATS) (Mundy et al., 2013) , were recruited (i.e., 50% of iCATS participants were in the lowest tertile and 50% were in the highest tertile of the CATS cohort; see the iCATS protocol (Simmons et al., 2014) for further details). Note that the iCATS recruitment procedure was designed to maximize variance in hormone levels in the sample, and that while recruitment was based on groups, those children that later participated in iCATS brain imaging had a distribution of hormone levels similar to children in FACTS (i.e., positively skewed). The samples did not differ in sex distribution (p ¼ 0.475), but did differ on socioeconomic status (SES), as assessed by a measure of neighborhood disadvantage (http://www.abs.gov.au/websitedbs/D3310114.nsf/home /Seifa_entry_page), such that FACTS participants had lower SES (p < 0.001), consistent with the original recruitment strategy.
Both studies involved two waves of data collection, both involving Magnetic Resonance Imaging (MRI) of the brain (same scanner), and measurement of physical maturation and hormone levels from saliva samples (using identical assay techniques). Exclusion criteria for both studies included: MRI contraindications; history of head trauma or loss of consciousness; history of clinically significant developmental or intellectual disorder; and, use of psychotropic medication. Across both studies, 249 participants provided MRI, physical maturation and hormone data at one (n ¼ 85, 34% of FACTS and 38% of iCATS participants) or two (n ¼ 164, 66% of FACTS and 62% if iCATS participants) waves (409 datasets covering the age range 8-13 years, see Table 1 for further details). See Supplementary Table S1 for further details of participant numbers at each wave. Written consent was obtained from the parent/ guardian and verbal assent from the child. Ethics approval for iCATS was granted by the Royal Children's Hospital Human Research Ethics Committee (HREC#32171), and for FACTS by The University of Melbourne Human Research Ethics Office (HREC#1339904).
MRI
Acquisition
Neuroimaging data were acquired on a 3 T S TIM Trio scanner (Siemens, Erlangen, Germany) at the Murdoch Children's Research Institute in Melbourne, Australia. All participants completed a mock-scan prior to their actual scan at Wave 1 (which was repeated at Wave 2 if the participant wished or researcher deemed it appropriate). All children were also given information on MRI (including a video) prior to participating in order to familiarize them with the procedure and minimize anxiety as much as possible. For the MRI scan, participants lay supine in a 32-channel head coil. Structural T1-weighted images were acquired as follows: FACTS: repetition time ¼ 2530 ms; echo time 1 ¼ 1.74 ms, echo time 2 ¼ 3.6 ms, echo time 3 ¼ 5.46 ms, echo time 4 ¼ 7.32 ms; flip angle ¼ 7 , field of view ¼ 256 Â 256 mm 2 , producing 176 contiguous sagittal slices with 1.0 mm 3 voxel dimensions; iCATS: repetition time ¼ 1900 ms, echo time ¼ 2.24 ms, flip angle ¼ 9 , field of view ¼ 230 mm 2 , resulting in 208 contiguous sagittal slices with voxel dimensions 0.9 mm 3 . Image quality was visually inspected at the time of acquisition by the radiographer. If movement artefact was detected and time permitted, with the participant's consent, the sequence was repeated.
PGV measurement
Total PGV (mm 3 ) was computed manually using the software ANALYZE 11.0 (AnalyzeDirect, Overland Park, KS, USA). This approach is consistent with a previously established technique (Pariante et al., 2004) and provides valid and reliable volumetric measurements of the pituitary gland. Pituitary glands were traced in the coronal plane, where best visualized (Pariante et al., 2004) and measurements excluded the infindibular stalk but included the hyper-intense region of the posterior pituitary gland. The boundary was delineated by the diaphragm sellae, superiorly; the sphenoid sinus, inferiorly; and the cavernous sinuses, bilaterally. The volume of pituitary gland was calculated by summing voxels within the traced boundary of each 2D coronal slice (approx. 8-12 slices per gland). PGVs were traced by one of four trained individuals, who were blinded to participant characteristics. All raters achieved reliability against a set of ten previously traced scans by an expert rater. Inter-and intra-rater reliability intraclass correlation coefficients were >0.8 for all raters. Intracranial volume (ICV) was estimated for all scans using Freesurfer (cross-sectional) v5.3 (Fischl et al., 2002) .
Saliva collection and assaying
At each wave of each study, at least two saliva samples were collected and averaged for analyses (to minimize proximal confounds that can influence salivary biomarkers). At Wave 1 (both studies) and Wave 2 FACTS, saliva samples were collected on the day prior to, and on the day of MRI scanning. At Wave 2 iCATS, two to four samples were collected with samples provided across consecutive weeks (including the day of scanning). Importantly, all samples were collected at waking given that variation in hormone levels is larger across different times of the day than across the same time of different days (Granger et al., 2004) . For each sample, children collected 2.5 ml of saliva in a test tube, via passive drool. Participants recorded the time they started collection of saliva and the duration of collection using a stopwatch. Any samples from participants who indicated that samples were provided more than 45 min after waking were excluded. Samples were frozen at À30 C, and prior to analysis, defrosted and centrifuged, with the supernatant assayed in duplicate for levels of DHEA, DHEA-S, and testosterone using Salimetrics ELISA kits. Samples from Wave 2 iCATS (only) were also assayed for estradiol levels. Although the primary aim of the study was to investigate adrenarcheal hormones, effects of estradiol were examined in follow-up models in order to assess possible influences of gonadarche in females. See Table 2 for inter-and intra-assay coefficients of variation.
Physical maturation
At all waves of both studies, parents completed the Tanner Stage Identification Parent Report (TSI-PR), a widely used and reliable measure of pubertal development (Dorn et al., 1990; Shirtcliff et al., 2009) . Recognizing that physical examination is not necessarily a gold standard measure of puberty (Chavarro et al., 2017) , correlations between parent report of Tanner stage and physical exam range from 0.75 to 0.87, suggesting good validity. Further, correlations are stronger for children/adolescents at lower Tanner stages (Dorn et al., 1990 ), suggesting that validity may be higher in the current sample. The TSI-PR consists of line drawings of female and male bodies corresponding with the Tanner stages of pubertal development. For females, parents choose from five stages on two sets of pictures, one for breast development and one for pubic hair development, while for males, parents choose from five stages on one set of pictures of genital and pubic hair development. For females, the higher score for breast or pubic hair development picture sets was used, if there was a discrepancy (Bond et al., 2006) . However, we also investigated pubic hair and breast development separately.
Statistical analysis
Levels of DHEA-S were corrected for flow rate because concentrations of this hormone in saliva decrease as flow rate increases (Vining et al., 1983) . Therefore, DHEA-S levels are presented as a function of time (ml/s x pg/ml ¼ pg/s). Sample assays below the limit of detection (LOD) of DHEA (5 pg/ml) were assigned a value of halfway between zero and the detectable limit, an approach consistent with previous research (Cohen and Ryan, 1989) . This was the case for 39 individuals (7 of which had undetectable values for both waves, while 32 individuals had undetectable values only for Wave 1). There were no individuals with undetectable levels of any other hormone. Hormone variables were positively 
Note that hormone values are based on log transformed variables. skewed and were thus log-transformed within each study wave to achieve a Gaussian distribution. Analyses were performed using a mixed models approach in R and package nlme (Pinheiro et al., 2014) . Mixed models allow for data hierarchies as observed in longitudinal datasets, and account for the fact that waves within a longitudinal dataset are nested within participants.
Age-related change in PGV
Mixed models were first used to determine age-related change in the PGV. In all models, sex, study sample (a dichotomous dummy variable: 0 ¼ FACTS, 1 ¼ iCATS) and SES were included as covariates. Study sample was included given that the included samples were recruited using different means, and SES was included because it differed between study samples (i.e., SES was higher in iCATS). The models followed a formal model-fitting procedure, whereby we started with a null model that included a fixed and a random intercept, to allow for individual differences in starting points and account for the repeated nature of the data. The null model with random intercept was compared against two additional models that tested (fixed effects) linear and quadratic age trajectories (age was grand mean-centered). Akaike Information Criterion (AIC, Akaike, 1974) values, in addition to log likelihood ratio tests, were used to test whether a null model, linear, or quadratic model best explained the relationship between age and PGV. A more complex model was adopted if the log likelihood ratio test was significant, and the AIC value was lower than the less complex model (Mills and Tamnes, 2014) .
In the next step, we added an interaction between sex and age to the best-fitting age model, and also added an interaction between sex and age squared in the case of a best-fitting quadratic age model. Improvement of model fit was again assessed with AIC values and log likelihood ratio tests. In a final step, we determined whether there were significant individual differences in the effects of age by adding a random-slope of age to the best-fitting model. The significance of the random term was also determined via AIC and a log likelihood ratio test. Any models where significant sex interactions were present were followed-up with separate mixed model analyses for males and females. Best fitting models were determined for males and females as above. All models were fit with full information maximum likelihood estimates.
The equation for a linear age model, for example, is:
Where Yij is PGV for the ith subject for the jth wave, β0 is the global intercept, u0j is the random intercept, X1ij is the value of X1 (timevarying factor, i.e., age) for the ith subject for the jth wave, X2i, X3i, and X4i are the values of X2, X3, and X4 (time-invariant factors, i.e., sex, sample and SES) for the ith subject, and eij are the subject residuals. The equation for a quadratic age model, for example, is:
The equation for a model with a linear age by sex interaction, for example, is:
The equation for a fixed and random linear age slope model, for example, is:
Where u1j ¼ random slope.
Age-related change in physical maturation and hormones
Although not of primary interest, we replicated the above analysis steps in order to determine age-related change in Tanner stage and each hormone.
Physical maturation & hormonal predictors of PGV development
We next tested whether physical maturation (i.e., Tanner stage) and
adrenarcheal hormonal (i.e., testosterone, DHEA, DHEA-S) markers explained variance in PGV development. We followed the same modelfitting procedure as above for each predictor. That is, we started with a model that contained fixed effects of sex, study sample, and SES, and a random intercept. We next tested whether linear and quadratic terms for the physical/hormonal predictor improved model fit, followed by sex interactions, and finally, random slopes. As above, model fit was assessed by evaluation of AIC values and log likelihood ratio tests, and significant sex interactions were followed-up with sex-specific analyses. There is no clear method for correcting for multiple tests when using various criteria for model fitting. However, we applied FDR correction based on the p value of the fixed effect of the primary predictor in the best fitting model to account for the four primary models run (Tanner, testosterone, DHEA and DHEAS predicting PGV). Of note, all predictors remained significant after FDR correction. Finally, we ran sets of follow-up models that a) included a fixed effect of age, in order to establish whether pubertal/hormone effects on PGV development exist over and above age, b) investigated the potential differential role of pubic hair versus breast maturation in PGV development in females, and c) investigated the role of estradiol in PGV development in iCATS Wave 2 females. These latter follow-up models were run to assess possible influences of gonadarcheal processes (i.e., breast development and estradiol production both result from gonadal development in females, Shirtcliff et al., 2009) . Similar analyses in males were not possible given that testosterone has both adrenal and gonadal origins.
Possible confounding variables
Eighteen participants (12 from iCATS, 6 from FACTS) reported steroid-based medication use within the three months prior to saliva collection at each wave. All analyses were repeated excluding these individuals. Further, given that PGV was associated with ICV (wave 1: r ¼ 0.285, p < 0.001, wave 2: r ¼ 0.217, p ¼ 0.002), all analyses involving PGV were repeated including ICV as a covariate.
Results
See Table 3 for bivariate correlations between all variables across both assessment waves. See Fig. 1 for an illustration of participants by age, Tanner stage and sex.
Age-related change in PGV
Model fit indices for models are listed in Table 4 . The relationship between PGV and age was best explained by a quadratic age by sex model, with a random age slope (see Table 5 and Fig. 2 ). Follow-up analyses by sex revealed that there was no effect of age on PGV for males (p ¼ 0.126). For females, PGV declined until approximately age 10.5 years, where it then showed an increase (quadratic age effect: p < 0.001). Although study sample (FACTS/iCATS) was included as a covariate in models, to further explore if differences in sample were contributing to findings, an age by study sample interaction term was added to the model to test whether age-related change was different in each sample. In this model, the age by study sample interaction was not significant (p ¼ 0.616), and the quadratic age by sex interaction remained significant (p < 0.001).
Age-related change in physical maturation and hormones
See Supplementary Tables S2 and S3 and Fig. S1 for results pertaining to age-related change in physical and hormonal variables. The relationship between Tanner stage and age was best explained by a model that included a quadratic age by sex effect, and a random age slope. Analyses by sex revealed quadratic age effects in both males (p < 0.001) and females (p < 0.001), whereby Tanner stage increased with age, with the steepest increase at latter ages (i.e., from age~10), and a more pronounced increase in females. DHEA-S change was best explained by a linear age by sex effect. Analyses by sex showed that levels increased for both males (p < 0.001) and females (p < 0.001), with the increase more pronounced for males. Testosterone change was best described by quadratic age with a random age slope. Levels increased with age, with the steepest increase at latter ages (i.e., from age~10). DHEA change was 
Physical & hormonal predictors of PGV development
All physical and hormonal variables were found to predict PGV. See Table S2 for model fit indices, and Table 6 for model statistics. The best fitting model for both Tanner stage and DHEA-S was one that included a linear puberty by sex interaction. Analyses with males and females separately revealed that higher Tanner stage and DHEA-S were associated with increased PGV in females (Tanner: p < 0.001, DHEA-S: p ¼ 0.001, see Fig. 3 ), but there were no associations in males (Tanner: p ¼ 0.166, DHEA-S: p ¼ 0.198).
The best fitting models for testosterone and DHEA both included a quadratic hormone by sex interaction term. The DHEA model also included a random slope. Increasing testosterone and DHEA levels were associated with quadratic PGV change in females (testosterone: p ¼ 0.005, DHEA: p ¼ 0.0003, see Fig. 3 ), whereby increases were most pronounced at higher hormone levels. In males, increasing testosterone was associated with a linear increase in PGV (p ¼ 0.005), but the association with DHEA was not significant (p ¼ 0.237).
Investigation of pubertal effects over and above age, and gonadal effects in females
The addition of a fixed age effect did not have an impact on the significance of physical/hormonal effects on PGV.
Models run for Tanner pubic hair and breast scores separately in females showed that pubic hair development predicted linear PGV change whereas breast development predicted quadratic PGV change. When both pubic hair and breast development were included in the model, only pubic hair development was a significant predictor of PGV change (see Supplementary Table S4 ). Further, DHEA (DHEA 2 p ¼ 0.004) and TST (TST 2 p ¼ 0.015), but not DHEAS (p ¼ 0.179), continued to be significant predictors of PGV in females when Tanner breast development was included as a covariate in models.
A regression model investigating associations between estradiol levels and PGV in iCATS Wave 2 females revealed that estradiol positively predicted PGV in females (p ¼ 0.003). We next tested whether independent effects of DHEA, DHEAS and TST were observed if estradiol was included in female models. DHEA (p ¼ 0.036), DHEAS (p ¼ 0.039), and TST (p ¼ 0.037) significantly predicted PGV when estradiol was also included as a predictor.
Assessment of influence of possible confounding variables
The exclusion of participants with recent steroid-based medication use did not impact the selection of best fitting model for any analyses. The inclusion of ICV as a covariate did not impact the selection of best fitting model for any PGV analysis.
Discussion
In a sample of 249 children with repeat neuroimaging, we demonstrate associations between pubertal hormones and PGV development from late childhood to early adolescence. While previous studies have found evidence for associations between gonadal hormones and PGV development, our findings suggest independent effects of hormones that play a key role in adrenarche, the first biochemical phase of puberty, in PGV development. While chronological age predicted PGV development in a sex-dependent manner, we found that DHEA, DHEA-S and testosterone (in addition to Tanner stage) explained variance in PGV development over and above age, and in a sex-dependent fashion.
We found non-linear associations between age and PGV that differed by sex. For males, PGV did not change with age, whereas for females, PGV decreased initially, but by approximately 10.5 years, PGV volumes began to increase. These findings are partly consistent with prior research, although different age ranges and methods used in prior studies make comparisons difficult. Increased PGV with age in females is consistent with previous work ( 2004; Peper et al., 2010; Takano et al., 1999; Wong et al., 2014) . The accelerating nature of the trajectory is also consistent with prior studies that have assessed nonlinear effects (MacMaster et al., 2007; Takano et al., 1999) , although our findings provide the first evidence of a nonlinear trajectory using a continuous measure of age (as opposed to age-band groups). Evidence for age-related PGV development in males is more mixed. Our finding of no association for males is consistent with one previous study (MacMaster et al., 2007) , but not with others (Peper et al., 2010; Takano et al., 1999) . It should be noted that not all previous studies have statistically tested for sex differences (e.g., Peper et al., 2010) , and all prior studies employed cross-sectional methods, and consequently were not able to examine within-subject change. As such, our findings provide an important contribution to the literature describing the age-related development of PGV during the childhood to adolescent transition.
Our findings suggest that indices of pubertal maturation also contribute to PGV developmental trajectories. We found that physical maturation (based on parent reported Tanner stage) was associated with PGV development, particularly in females. This finding is consistent with the one prior study to test this association (Wong et al., 2014) . Notably, while pubic hair and breast development were both associated with PGV growth, there was some evidence that pubic hair development was a more important predictor of PGV as compared to breast development (breast development no longer predicted PGV after taking account of pubic hair development) during the transition from childhood to adolescence. This finding suggests primary adrenal rather than gonadal influence on PGV growth across the age range studied (Shirtcliff et al., 2009) . Unlike Wong et al. (2014) , however, we did not find a positive association between physical maturation and PGV development in males. The lack of association in the present study is likely due to the fact that participants were younger than those in Wong et al., and there was restricted variance in physical maturation in males; most males in our sample were in Tanner stage 1-3 (see Fig. 1 ).
Our findings also suggest that hormonal changes during adrenarche predict sexually dimorphic PGV development. Our findings regarding testosterone in females were somewhat similar to those of Peper et al. (2010) , who found a weak (although non-significant) positive association between testosterone and PGV in females aged 10-15 years. Our findings for males were inconsistent with those of Peper et al. (2010) , who found no association. Our male findings were, however, consistent with those of Wong et al. (2014) , who found a positive association between testosterone and PGV in males, although they investigated older males aged 12-18 years. Mirroring the testosterone findings, we found that in females, DHEA and DHEA-S were associated with increased PGV development. However, in males there were no associations. This finding is partially consistent with our previous cross-sectional work with a subset of the current participants, where we found a positive association between both DHEA and DHEAS, and PGV, in both male and female children aged approximately nine years (Murray et al., 2016) . No other longitudinal research, however, has investigated associations between DHEA or DHEAS and PGV.
It has been suggested that the pronounced pituitary growth during adolescence reflects hypersecretion of gonadotropins LH and FSH (Takano et al., 1999) , and others have found that gonadal sex hormones are associated with PGV (Peper et al., 2010; Wong et al., 2014) . Indeed, we also found that estradiol was associated with PGV in a subsample of older females in the current study. However, adrenarcheal hormones continued to predict PGV in females after accounting for breast development and estradiol levels. Our findings thus suggest that adrenarcheal hormones are also associated with PGV development from late childhood into early adolescence (at least in females). Given that corticotropin-releasing hormone (CRH) from the hypothalamus and adrenocorticotropic hormone (ACTH) from the anterior pituitary gland either directly or indirectly trigger the release of DHEA, DHEA-S and testosterone, it is possible that larger PGV is associated with increased production of these hormones (particularly in females). However, we cannot confidently draw conclusions about causality or directionality from our findings.
It is unclear what may be driving the sex-differences in our findings. All hormones increased across the age range similarly in males and females. It is thus possible that larger PGV in males is not (or is only weakly) associated with increased production of adrenarcheal hormones. It may be that there are factors that regulate adrenal androgen secretion exogenous to the pituitary and adrenal gland (e.g., uncharacterized substances elsewhere from the pituitary (Parker, 1991) ). Based on previous findings regarding testosterone, in addition to the current findings of positive associations that were more pronounced in females compared to males, it is possible that the association between testosterone and PGV in males becomes stronger later in adolescence. This may be in part due to increased systemic testosterone levels that occurs with the onset of gonadarche (Sidiropoulou et al., 2012) . Given evidence for an association between estradiol and PGV development in females (Peper et al., 2010; Wong et al., 2014) , it is also possible that part of the association between DHEA and PGV in females is due to DHEA conversion to estradiol in the ovaries at latter ages captured in the sample (Campbell, 2003) . However, as noted above, DHEA appeared to be an independent predictor of PGV in older females in the sample. Finally, the sex differences found may be due to sexual dimorphism in androgen receptor density (McAbee and Don -Carlos, 1998) . Further research is required to understand the likely complex links between adrenal hormones, in addition to gonadal hormones, and PGV in males and females during this developmental period.
There are a number of limitations of the current study that are important to keep in mind when interpreting findings. First, pituitary gland measurement did not distinguish between the anterior and the posterior lobes of the pituitary gland. The former lobe produces and releases HPA axis-related hormones in addition to HPG-axis hormones, as well as growth hormone, thyroid-stimulating hormone, and prolactin. The posterior lobe on the other hand is involved in the secretion of oxytocin and vasopressin, and is an extension of the hypothalamus, comprising axonal extensions (Tran et al., 2004) . As such, total PGV may introduce variance unrelated to the HPA hormones of interest here. It is worth noting, however, that the posterior pituitary constitutes less than 20% of the total pituitary volume (Pariante et al., 2004) and as such, the changes in volume we have described are likely due to changes in the volume of the anterior pituitary. Second, and related, we did not have measures of estradiol or other sex hormones or gonadotropins across all assessment waves. Third, we did not have physical maturation data based on physical exam, or other more intensive measures, such as MRI imaging of gonads. Finally, we aggregated data across two separate studies to increase the age-span covered, and power. Although there were some differences between the samples, almost identical protocols were used in both studies, one expert PGV tracer oversaw training and tracing of pituitary glands across both datasets, and we covaried for study sample and SES (which differed between studies).
Conclusions
We report the first longitudinal evidence of associations between physical maturation and adrenarcheal hormones and PGV development during the childhood to adolescent transition. We found evidence that these physical and hormonal measures predicted non-linear and sexdependent trajectories of PGV over and above age, with generally stronger associations found for females that appear not accounted for by gonadal development. Further work is needed to understand the role of other hormones in PGV development, in addition to the implications of individual differences in hormonally-influenced PGV trajectories for functional outcomes. For example, given abnormalities in PGV found in depressed and anxious populations, pubertal-related increases in PGV in females may have implications for the pronounced increase in onset of anxiety and depressive disorders that occurs primarily in females during childhood and adolescence.
